SecBot SecBot
PRESS-RELEASE ·Filed Nov 16, 2026

APMD

Apnimed, Inc.
NEUTRAL
Impact 5/10
Processed15h 46m ago Wirepress-3403484
Press release · Earnings

Price Chart

Loading chart...

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3403484

Track record

11 reports on APMD

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +18.84% at T+20 after the Jul 31, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.28 Now $16.28 +0.00% settles Dec 16
  2. Nov 16, 2026today Press Release Neutral 5/10 Viewing Entry price pending
  3. Nov 13, 20263d ago 10-Q/A Neutral 4/10 Entry $17.41 Now $16.28 −6.49% settles Dec 15
  4. Nov 13, 20263d ago 8-K Bearish 6/10 Entry $17.41 Now $16.28 +6.49% settles Dec 15
  5. Nov 4, 202612d ago SC 13G Neutral 4/10 Entry $15.30 Now $16.28 +6.41% settles Dec 3
  6. Aug 5, 202614w ago Insider Cluster Bullish 7/10 Entry $27.88 to $27.81 Now $16.28 −41.61% ▼ −0.25% −0.85% vs SPY
  7. Aug 3, 202615w ago Insider Buy Bullish 7/10 Entry $25.71 to $26.85 Now $16.28 −36.68% ▲ +4.43% +5.67% vs SPY
  8. Jul 31, 202615w ago 424B4 Mixed 6/10 Entry $25.00 to $26.25 Now $16.28 −34.88% ▲ +5.00% +3.76% vs SPY
  9. Jul 31, 202615w ago EFFECT Bullish 7/10 Entry $25.00 to $29.71 Now $16.28 −34.88% ▲ +18.84% +15.85% vs SPY
  10. Jul 30, 202615w ago 3 Neutral 3/10 Entry $25.00 to $29.71 Now $16.28 −34.88% ▲ +18.84% +15.85% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens Wed (9h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026

Fresh APMD Intelligence

Analysis is for subscribers only.

Subscribe for Full Access